Compare Cashlez Worldwide Indonesia Tbk. (CASH) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cashlez Worldwide Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cashlez Worldwide Indonesia Tbk. trades at Rp202 (market cap 300.54B, 2.79M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Cashlez Worldwide Indonesia Tbk. is the larger of the two by market cap, and Cashlez Worldwide Indonesia Tbk. is more actively traded (2.79M versus 71K). Which is the better fit depends on your goals.
| CASH | OBAT | |
|---|---|---|
Market Cap | 300.54B | 167.37B |
Volume | 2.79M | 71K |
Lot | 27.88K | 710 |
Turnover | 587.94M | 17.51M |
Average Price | 210.91 | 246.63 |
Value | 587.94M | 17.51M |
Indicative Equilibrium Price | 202 | 246 |
Indicative Equilibrium Volume | 652 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cashlez Worldwide Indonesia Tbk.
PT Cashlez Worldwide Indonesia Tbk (the Company) was established based on Notarial DeedNo. 1 dated January 12, 2015 of public notary Novita Puspitarini, S.H. The Company started its commercial operations in 2016.
Read more on CASH →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
